Urokinase API
Technical Overview for Pharmaceutical Teams & Procurement
Practical Overview
In human pharmaceutical development and manufacturing, the decision to adopt a particular enzyme intermediate like Urokinase is based on measured performance in analytical systems, reproducibility across batches, and documented handling behavior . Medical ingredient specialists rely on data and process experience to determine whether a material fits within their internal quality frameworks.
This page provides clear, practical information for those evaluating Urokinase API for integration into sterile injectable products, analytical method development, or controlled manufacturing workflows.
Material Identity & Specifications
- ▸ Product: Urokinase API (Human enzyme intermediate)
- ▸ CAS Number: 9012-68-6
- ▸ Physical Form: White to off-white lyophilized powder
- ▸ Assay / Activity: Lot-verified enzymatic activity with numeric documentation
- ▸ Solubility: Documented behavior in validated buffer systems
- ▸ Storage: 2–8 °C (Short-term); -20 °C (Long-term); Protect from moisture/light
Each lot is released only after analytical review against clearly defined acceptance windows.
Evaluation for Lab & Manufacturing
Overlaid on HPLC/LC traces and quantified against internal standards for efficient method transfer.
Sample orders allow documentation of buffer compatibility, filtration performance, and pH/ionic strength behavior.
Control humidity during transfer and prevent freeze-thaw cycles using lot-specific stability summaries.
Batch Documentation
- ▸ Certificate of Analysis (COA): Numeric activity, assay, and impurity breakdown
- ▸ MSDS & TDS: Safety and specific handling notes included
- ▸ Batch Traceability: Records ready for direct ERP/LIMS system integration
Packaging & Logistics
Primary Packaging: Moisture-resistant vials with desiccant to preserve enzymatic dryness.
Labeling: Clear batch/lot identifiers suitable for direct laboratory data entry.
Transport: Temperature-controlled options available to maintain enzyme integrity during transit.
Recommended Procurement Path
Lab Evaluation: Sample orders to confirm analytical match.
Qualification: Review of COA and impurity data against internal standards.
Supply Planning: Transition to scheduled bulk supply and packaging formats.
FAQ - Practical & Technical
Q: Is this API intended for direct therapeutic use?
A: No - Urokinase API is supplied strictly as an intermediate for pharmaceutical formulation and manufacturing.
Q: How should this API be stored?
A: Store sealed and dry; short-term at 2–8 °C; long-term at -20 °C. Protect from moisture and light.
Q: Is custom packaging available?
A: Yes - labels and packaging can be tailored to meet specific regulatory or internal workflow requirements.
Operational Integration
A phased approach that mitigates risk while aligning material intake with your project timelines.
Hot Tags: urokinase, China urokinase manufacturers, suppliers, factory, Highly Purified FSH, Human Chorionic Gonadotropin, 37025-55-1, Oxitocina Humana, 120287-85-6, Highly Purified Urofollitropin
